Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0000899243-23-000619

Options or other derivatives

  • Director acquired 1,792 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Ros Matthew · Director

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-01-03 Grant or award : show line 1 in the form Stock Option (Right to Buy) +1,792 $7.19 $12,876 1,792 D
Loading xslF345X03/doc4.xml…